Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

Outcomes of Surgically Ineligible Patients With Multivessel CAD

ClinicalTrials.gov ID: NCT02996877

Public ClinicalTrials.gov record NCT02996877. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 8, 2026, 4:27 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Outcomes of Percutaneous Revascularization for Management of Surgically Ineligible Patients With Multivessel or Left Main Coronary Artery Disease: A Prospective Registry

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The OPTIMUM registry is a minimal risk observational study that uses a prospective cohort design to follow patients who have multivessel or left main coronary artery disease ("surgical anatomy" according to ACC/AHA Appropriateness Criteria for PCI12) and are deemed ineligible for coronary artery bypass surgery. It is anticipated that 20 sites will be selected to participate in the registry from a national network of leading centers across the United States with recognized expertise in both complex PCI and coronary artery bypass surgery. We will invite leading cardiac centers, as defined by US News and World reports rankings for heart care. Additional sites may be added to meet the target enrollment goal.

Study identification

NCT ID
NCT02996877
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Saint Luke's Health System
Other
Enrollment
750 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 14, 2016
Primary completion
Jun 21, 2020
Completion
Jun 21, 2020
Last update posted
Oct 23, 2025

2016 – 2020

United States locations

U.S. sites
21
U.S. states
15
U.S. cities
18
Facility City State ZIP Site status
Banner University Medical Center Phoenix Arizona 85006
Unifersity of California San Diego Medical Center San Diego California 92037
Washington Hospital Center Washington D.C. District of Columbia 20010
Emory University Hospital Midtown Atlanta Georgia 30308
Piedmont Heart Institute Atlanta Georgia 30606
University of Kansas Medical Center Kansas City Kansas 66160
Massachusetts General Hospital Boston Massachusetts 02114
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
Henry Ford Hospital Detroit Michigan 48202
Mayo Clinic Rochester Minnesota 55905
Saint Luke's Hospital of Kansas City Kansas City Missouri 64111
Washington University in Saint Louis St Louis Missouri 63110
Northwell Health System Manhasset New York 11030
Columiba University Medical Center New York New York 10032
University Hospitals Cleveland Medical Center Cleveland Ohio 44106
Cleveland Clinic Cleveland Ohio 44195
Geisinger Health System Danville Pennsylvania 17822
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213
University of Virginia Medical Center Charlottesville Virginia 22908
University of Washington Medical Center Seattle Washington 98195
Charleston Area Medical Center Charleston West Virginia 25304

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02996877, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 23, 2025 · Synced Sep 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02996877 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →